G\u00fctersloh\/London \u2014 Oakley Capi\u00adtal (\u201cOakley\u201d), a leading pan-Euro\u00adpean mid-market private equity inves\u00adtor, has acqui\u00adred a majo\u00adrity stake in vitro\u00adcon\u00adnect, a leading open access plat\u00adform in Germany, through its Oakley Capi\u00adtal Origin Fund II. This was announ\u00adced by the company. The invest\u00adment is being made toge\u00adther with foun\u00adder and CEO Dirk Paster\u00adnack and the manage\u00adment team, who will conti\u00adnue to lead the company. The tran\u00adsac\u00adtion is expec\u00adted to be comple\u00adted by the end of the first half of 2024, subject to the neces\u00adsary regu\u00adla\u00adtory approvals.<\/p>\n
G\u00fcters\u00adloh-based vitro\u00adcon\u00adnect brings broad\u00adband connec\u00adtion provi\u00adders toge\u00adther with resel\u00adlers using a proprie\u00adtary soft\u00adware plat\u00adform and inter\u00adface logic. The company\u2019s custo\u00admers include most of the leading tele\u00adcom\u00admu\u00adni\u00adca\u00adti\u00adons provi\u00adders in Germany. In addi\u00adtion, vitro\u00adcon\u00adnect offers process auto\u00adma\u00adtion, network opera\u00adtion, trading and white label services via its \u201cCarrier Aggre\u00adga\u00adtion Plat\u00adform\u201d (CAP).<\/p>\n
The CAP-gene\u00adra\u00adted open access process services from vitro\u00adcon\u00adnect help custo\u00admers to use broad\u00adband networks more effi\u00adci\u00adently and reduce the tran\u00adsac\u00adtion costs of all parties invol\u00adved. Thanks to this unique offe\u00adring, the company has conti\u00adnuously expan\u00added its custo\u00admer base of network opera\u00adtors and resel\u00adlers. In addi\u00adtion, mini\u00admal custo\u00admer fluc\u00adtua\u00adtion, strong custo\u00admer loyalty and a high propor\u00adtion of recur\u00adring sales have contri\u00adbu\u00adted to consis\u00adtent and profi\u00adta\u00adble double-digit growth over the past three years.<\/p>\n
As a pioneer of whole\u00adsale acti\u00advi\u00adties in the highly frag\u00admen\u00adted and tech\u00adno\u00adlo\u00adgi\u00adcally hete\u00adro\u00adge\u00adneous German broad\u00adband market, vitro\u00adcon\u00adnect has an excep\u00adtio\u00adnally good market posi\u00adtion to bene\u00adfit from the strong growth in \u201cFiber to the Home\u201d (FTTH) tech\u00adno\u00adlogy and to help reduce the gap between Germany and other Euro\u00adpean count\u00adries in the fiber optic market.<\/p>\n
Curr\u00adently, the propor\u00adtion of German house\u00adholds with a connec\u00adtion to the fiber-optic broad\u00adband network lags far behind the rest of Europe. This will lead to signi\u00adfi\u00adcant invest\u00adments and considera\u00adble growth poten\u00adtial in the coming years, with a simul\u00adta\u00adneous increase in the number of house\u00adholds with fiber optic connec\u00adtions from 3 million today to 29 million in 2029 and 39 million in 2035.<\/p>\n
The invest\u00adment in vitro\u00adcon\u00adnect fits seam\u00adlessly into Oakley\u2019s long track record of part\u00adne\u00adring with high-growth, profi\u00adta\u00adble, foun\u00adder-led compa\u00adnies. Oakley\u2019s most rele\u00advant tran\u00adsac\u00adtions in adja\u00adcent sectors include soft\u00adware compa\u00adnies such as WebPros, Hori\u00adzons Opti\u00adcal and Alerce.<\/p>\n
The invest\u00adment in vitro\u00adcon\u00adnect is the first invest\u00adment from Origin Fund II and follows the recently announ\u00adced acqui\u00adsi\u00adtion of Hori\u00adzons Opti\u00adcal via its prede\u00adces\u00adsor fund, Origin Fund I.<\/p>\n
Peter Dubens, Co-Foun\u00adder and Mana\u00adging Part\u00adner of Oakley Capi\u00adtal<\/strong>said: \u201cvitro\u00adcon\u00adnect is excel\u00adlently posi\u00adtio\u00adned to bene\u00adfit from the market uphe\u00adaval in Germany trig\u00adge\u00adred by the switch to fiber optic tech\u00adno\u00adlogy. The company has an excep\u00adtio\u00adnally strong market posi\u00adtion based on custo\u00admer focus, high tech\u00adni\u00adcal compe\u00adtence and an excel\u00adlent manage\u00adment team. We look forward to working with Dirk Paster\u00adnack and his team, combi\u00adning vitro\u00adcon\u00adnec\u00adt\u2019s core compe\u00adten\u00adcies with our own indus\u00adtry exper\u00adtise and acce\u00adle\u00adra\u00adting the company\u2019s future growth together.\u201d<\/p>\n Dirk Paster\u00adnack, foun\u00adder and CEO of vitro\u00adcon\u00adnect, said: \u201cWe were convin\u00adced by Oakley\u2019s exten\u00adsive exper\u00adtise in the soft\u00adware and tele\u00adcom\u00admu\u00adni\u00adca\u00adti\u00adons sector and their proven ability to support compa\u00adnies in phases of market disrup\u00adtion. In Oakley, we have found an ideal part\u00adner to jointly embark on the next phase of vitro\u00adcon\u00adnec\u00adt\u2019s growth plan.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":" G\u00fctersloh\/London \u2014 Oakley Capi\u00adtal (\u201cOakley\u201d), a leading pan-Euro\u00ad\u00adpean mid-market private equity inves\u00adtor, has acqui\u00adred a majo\u00adrity stake in vitro\u00adcon\u00adnect, a leading open access plat\u00adform in Germany, through its Oakley Capi\u00adtal Origin Fund II. This was announ\u00adced by the company. The invest\u00adment is being made toge\u00adther with foun\u00adder and CEO Dirk Paster\u00adnack and the manage\u00adment team, [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":51411,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-51414","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\n